n a clinical trial on more persons than in phase I; intended to evaluate the efficacy of a treatment for the condition it is intended to treat; possible side effects are monitored
MEIP Starts Phase II Study on Pracinostat MEI Pharma, Inc. commenced a phase II study of Pracinostat in combination with Vidaza (azacitidine) for the treatment of myelodysplastic syndrome (MDS)
June 19, 2013 - Zacks via Yahoo! Finance
MEIP Starts Phase II Study on Pracinostat - Analyst Blog MEI Pharma, Inc. ( MEIP ) recently commenced a phase II study of Pracinostat in combination with Vidaza (azacitidine) for the treatment of myelodysplastic syndrome (MDS). The
June 19, 2013 - Nasdaq